Better Context Better Decisions

Context counts in life sciences. The FENIX analyst team is tirelessly using its experience to put you in a position to succeed. Below, our readers without corporate access will find a wealth of contextualized life science insight ready to be purchased in the FENIX Marketplace. If our content sharing limitations are inconvenient for you, reach out to Brady for unlimited corporate, institutional, or individual access.

lilly cover image
$599
Posted in: Dual/triple agonist, GLP-1RA, Other Oct 29 | 2019New Lilly Ph1 Trial; Likely GGG Tri-agonistPurchase Blast
merck and pfizer cover image
$599
Posted in: GLP-1RA, SGLT2i Oct 29 | 2019Merck and Pfizer Q3 '19 Earnings UpdatesPurchase Blast
insulet cover image
$599
Posted in: Bolus Insulin, Glucose Monitoring, Insulin Delivery Oct 25 | 2019Omnipod Approved to use Novo's Fiasp; Senseonics Now Covered on HumanaPurchase Blast
astrazeneca cover image
$599
Posted in: Dual/triple agonist, SGLT2i Oct 24 | 2019AstraZeneca Q3 '19 Earnings UpdatePurchase Blast
lilly cover image
$599
Posted in: Basal Insulin, Bolus Insulin, Dual/triple agonist, GLP-1RA, Glucagon, SGLT2i Oct 23 | 2019Lilly Q3 '19 Earnings Update; Conterno to RetirePurchase Blast
medtronic cover image
$599
Posted in: Glucose Monitoring, Insulin Delivery Oct 23 | 2019Thoughts on Medtronic Diabetes Leadership ChangePurchase Blast
novo cover image
$599
Posted in: Bolus Insulin, Insulin Delivery Oct 23 | 2019Fiasp Approved for Pump Use in USPurchase Blast
$599
Posted in: Glucose Monitoring, Insulin Delivery, Other Oct 15 | 2019Abbott and Tandem partnership; Livongo partners with VSP Vision CarePurchase Blast
JnJ cover image
$599
Posted in: SGLT2i Oct 15 | 2019J&J Q3 '19 Earnings UpdatePurchase Blast
european medicines agency cover image
$599
Posted in: Basal Insulin, Bolus Insulin, Glucagon, SGLT2i Oct 14 | 2019Lilly Nasal Glucagon CHMP Opinion This Week (CHMP Agenda October 14-17)Purchase Blast
$599
Posted in: Glucose Monitoring Oct 14 | 2019Abbott Libre 2 US Approval Conspicuously Late?Purchase Blast
1 67 68 69 70 71 96

Get the Latest Analysis

Stay informed and aligned with frequent updates to keep a pulse on the industry.

If you already have an account, please log in. If you have any questions or would like to subscribe to our services, please contact Brady.